Dominik Imfeld

Dr. Dominik Imfeld

DSM Nutritional Products, Research and Development, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EJEileen Jackson
Eileen Jackson
MHMarc Heidl
Marc Heidl
DIDominik Imfeld
Dominik Imfeld
LMLaurent Meeus
Laurent Meeus
RSRolf Schuetz
Rolf Schuetz
Remo CampicheRemo Campiche
Remo Campiche
One of the first lines of cutaneous defense against photoaging is (a) the synthesis of melanin and (b) the initiation of an oxidative stress response to protect skin against the harmful effects of solar radiation. Safe and selective means to stimulate epidermal pigmentation associated with oxidative stress defense are; however, scarce. Activation of the melanocortin-1 receptor (MC1R) on epidermal melanocytes represents a key step in cutaneous pigmentation initiation and, additionally, it regulates cellular defense mechanisms like oxidative stress and DNA-repair. Thus, making the activation of MC1R an attractive strategy for modulating skin pigmentation and oxidative stress. In this context, we designed and synthesized pentapeptides that act as MC1R agonists. These peptides bound, with high potency, to MC1R and activated cAMP synthesis in CHO cells expressing human MC1R. Using one lead pentapeptide, we could show that this activation of MC1R was specific as testing the activation of other G-protein coupled receptors, including the MC-receptor family, was negative. In vitro efficacy on mouse melanoma cells showed similar potency as for the synthetic MC1R agonist alpha-melanocyte stimulating hormone (NDP-alpha-MSH). Moreover, we could reproduce this activity in human skin tissue culture. The lead pentapeptide was able to induce ex-vivo protein expression of key melanogenesis markers melanocyte inducing transcription factor (MITF), tyrosinase (TYR), and tyrosinase-related protein 1 (TYRP-1). Concerning oxidative stress response, we found that the pentapeptide enhanced the activation of Nrf2 after UVA-irradiation. Our results make this pentapeptide an ideal candidate as a skin pigmentation enhancer that mimics alpha-MSH and may also have anti-photoaging effects on the skin.

17 August 2021 in International Journal of Cosmetic Science
Verified
Journal Article
Open access
PDF file
ARAnthony V. Rawlings
Anthony V. Rawlings
EWEliane Wandeler
Eliane Wandeler
IBIgor Bendik
Igor Bendik
PFPascale Fuchs
Pascale Fuchs
JMJean‐Marc Monneuse
Jean‐Marc Monneuse
RSRolf Schütz
Rolf Schütz
Introduction: We report on the in vitro and ex vivo effects of chiral (R)‐10‐hydroxystearic acid (10‐HSA) compared with other mono‐hydroxystearic acid regioisomers and stearic acid (SA) together with its benefit when combined with retinol.Methods: Following treatment with hydroxystearic acids peroxisomal proliferator‐activated receptor alpha (PPARα) activity was determined in a luciferase reporter gene assay, collagen type I was assessed in primary human dermal fibroblasts by immunohistochemistry, modification of the intracellular fibroblast collagen proteome was studied by mass‐spectrometry‐based proteomics and collagen type III was assessed by immunohistochemistry on human ex vivo skin.Results: 10‐HSA was the most effective PPARα agonist (15.7× induction; p < 0.001), followed by 9‐HSA (10.1× induction) and then 12‐HSA (4.9× induction) with 17‐HSA (1.7× induction) being similar to the effects of stearic acid (1.8× induction). Collagen type I levels were increased in primary human fibroblasts by 2.12× and 1.56× for 10‐HSA and 9‐HSA, respectively, in vitro with the10‐HSA being significant (p < 0.05), whereas 12‐HSA and SA had no statistical effect over the untreated control. 10‐HSA and 12‐HSA modified the intracellular fibroblast collagen proteome slightly with significant increases in collagen alpha‐1 (VI) and alpha‐3 (VI) proteins but only 10‐HSA increased levels of collagen alpha‐2 (V), alpha‐1 (III), alpha‐1 (I) and alpha‐2 (I) (all p < 0.05) with the increases being significantly different between 10‐HSA and 12‐HSA for collagen alpha‐1 (I), collagen‐3 (VI) and collagen alpha‐2 (I) (p < 0.01). Collagen type III in ex vivo skin was increased +47% (p < 0.05) by 0.05% (1.7 mM) retinol, +70% (p < 0.01) by 0.01% (0.33 mM) 10‐HSA and the combination increased levels by +240% (p < 0.01 for either ingredient).Conclusion: Chiral (R)‐10‐HSA has been shown to be superior to 9, 12 and 17‐HSA as a PPARα agonist. Moreover, 10‐HSA stimulated collagen synthesis in monolayer fibroblast culture as assessed by proteomics and immunohistochemically. Furthermore, we also show the synergistic effects of 10‐HSA with retinol on collagen III synthesis in skin explants. These results further highlight the efficacy of 10‐HSA as a cosmetically acceptable PPARα agonist and anti‐ageing ingredient.

23 June 2022 in International Journal of Cosmetic Science
Verified
Journal Article
Open access
RSRiccardo Sfriso
Riccardo Sfriso
JCJoshua Claypool
Joshua Claypool
MRMagalie Roche
Magalie Roche
DIDominik Imfeld
Dominik Imfeld
Background Facial skin is a particularly complex environment made of different skin types such as sebaceous (forehead) and dry (cheeks). The skin microbiota composition on different facial sites has not yet been addressed. Methods We conducted a 4-week-long, single-centre, randomized and placebo-controlled clinical study involving 23 Caucasian females. We assessed both bacterial composition on five different facial areas and the microbiome modulatory effects resulting from the topical application of a plant extract (Epilobium fleischeri). Skin microbiome samples were collected before and after 4 weeks of product application. Microbiota profiling was performed via 16S rRNA gene sequencing, and relative abundance data were used to calculate differentials via a multinomial regression model. Results Via 'reference frames', we observed shifts in microbial composition after 4 weeks of twice-daily product application and identify certain microbiota species, which were positively associated with the application of the product containing the Epilobium fleischeri extract. Staphylococcus hominis, Staphylococcus epidermidis, and Micrococcus yunnanensis appeared to be significantly enriched in the final microbiota composition of the active treatment group. Conclusion Facial skin was found to be colonized by an heterogenous microbiota, and the Epilobium fleischeri extract had a modulatory effect on commensal bacteria on the different facial sites.

7 August 2024 in International Journal of Cosmetic Science
Verified
Journal Article
Open access
DIDominik Imfeld
Dominik Imfeld
AFAndré Fischer
André Fischer
LBLeithe Budel
Leithe Budel
CSClarissa Stoll
Clarissa Stoll
RSRolf Schütz
Rolf Schütz
ARAnthony Vincent Rawlings
Anthony Vincent Rawlings
Lecithin:retinol acyltransferase (LRAT) is the main enzyme catalysing the esterification of retinol to retinyl esters and, hence, is of central importance for retinol homeostasis. As retinol, by its metabolite retinoic acid, stimulates fibroblasts to synthesize collagen fibres and inhibits collagen‐degrading enzymes, the inhibition of LRAT presents an intriguing strategy for anti‐ageing ingredients by increasing the available retinol in the skin. Here, we synthesized several derivatives mimicking natural lecithin substrates as potential LRAT inhibitors. By exploring various chemical modifications of the core scaffold consisting of a central amino acid and an N‐terminal acylsulfone, we explored 10 different compounds in a biochemical assay, resulting in two compounds with IC50 values of 21.1 and 32.7 μM (compounds 1 and 2), along with a simpler arginine derivative with comparative inhibitory potency. Supported by computational methods, we investigated their structure–activity relationship, resulting in the identification of several structural features associated with high inhibition of LRAT. Ultimately, we conducted an ex vivo study with human skin, demonstrating an increase of collagen III associated with a reduction of the skin ageing process. In conclusion, the reported compounds offer a promising approach to boost retinol abundance in human skin and might present a new generation of anti‐ageing ingredients for cosmetic application.